ClinicalTrials.Veeva

Menu

Heart Rate Variability in White Coat Hypertension and Essential Hypertension

R

Regional Hospital Holstebro

Status

Completed

Conditions

Healthy
Essential Hypertension
White Coat Hypertension

Treatments

Procedure: Monitoring of heart rate variability

Study type

Observational

Funder types

Other

Identifiers

NCT00286884
MED.RES.HOS.2003.01.LBM

Details and patient eligibility

About

The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.

Sex

All

Ages

30 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 30-70 years
  • office BP >150/95 mmHg and 24-h ambulatory BP =/>135/85 mmHg
  • office BP >150/95 mmHg and 24-h ambulatory BP <135/85 mmHg
  • office BP <150/95 mmHg and 24-h ambulatory BP <135/85 mmHg

Exclusion criteria

  • Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
  • neoplastic disease
  • daily use of medicine
  • alcohol abuse
  • abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
  • pregnancy
  • unwillingness to participate

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems